rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Catherine M. Szyman

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Masimo; Director, Inari Medical; CVP, Critical Care, Edwards Lifesciences; Director, Outset Medical; SrVP & Pres Diabetes, Medtronic.

In numbers

Trades disclosed
319
Buys
2
Sells
61
Bought
$1.6M
Sold
$49.9M
Companies
5
Companies where not an officer
2
First trade
10 Jul 2008
Last trade
10 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
MasimoDirector, Officer · Medical Devices · last 10 Jun 20260 buys · 0 sells
EW Edwards LifesciencesOfficer · Medical Devices · last 3 Sep 20241 buy · 56 sells
MedtronicOfficer · last 17 Apr 20140 buys · 5 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Inari MedicalDirector · last 19 Feb 20251 buy · 0 sells
OM Outset MedicalDirector · Medical Devices · last 31 May 20230 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 12 Jun 2026MasimoMedical DevicesSEC FORM 4 Code D$1.4M7,605 at $180.00filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code D—22,283filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code D—6,306filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivativeSEC FORM 4 Code D—22,283filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivativeSEC FORM 4 Code D—6,306filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivativeSEC FORM 4 Code D—39,904filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivativeSEC FORM 4 Code D$251K18,617 at $13.48filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivativeSEC FORM 4 Code D$8.9M49,243 at $180.00filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code D—39,904filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code D$251K18,617 at $13.48filing
10 Jun 2026filed 12 Jun 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code D$8.9M49,243 at $180.00filing
10 Jun 2026filed 12 Jun 2026MasimoSEC FORM 4 Code D$1.4M7,605 at $180.00filing
11 Mar 2026filed 16 Mar 2026MasimoMedical DevicesSEC FORM 4 Code M—2,101 at $0.00filing
11 Mar 2026filed 16 Mar 2026MasimoMedical DevicesSEC FORM 4 Code F$188K1,069 at $175.47filing
11 Mar 2026filed 16 Mar 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code M—2,101 at $0.00filing
11 Mar 2026filed 16 Mar 2026Masimooption or derivativeSEC FORM 4 Code M—2,101 at $0.00filing
11 Mar 2026filed 16 Mar 2026MasimoSEC FORM 4 Code M—2,101 at $0.00filing
11 Mar 2026filed 16 Mar 2026MasimoSEC FORM 4 Code F$188K1,069 at $175.47filing
6 Mar 2026filed 10 Mar 2026Masimooption or derivative · Medical DevicesSEC FORM 4 Code A—39,904 at $0.00filing
6 Mar 2026filed 10 Mar 2026Masimooption or derivativeSEC FORM 4 Code A—39,904 at $0.00filing

Sectors

Health Care57
Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Daniel J. LippisCvp, Tavr · Cvp, Tavr at Edwards Lifesciences, filing Form 4 there in the last year
Andrew M. DahlSVP, Corporate Controller · SVP, Corporate Controller at Edwards Lifesciences, filing Form 4 there in the last year
Wayne MarkowitzCvp, Japac · Cvp, Japac at Edwards Lifesciences, filing Form 4 there in the last year
Daveen ChopraCVP, TMTT, Surgical & IHFM · CVP, TMTT, Surgical & IHFM at Edwards Lifesciences, filing Form 4 there in the last year
Annette BrulsCvp, Emeacla · Cvp, Emeacla at Edwards Lifesciences, filing Form 4 there in the last year
Bernard J. ZovighianCEO · Also traded EW in the last 90 days